Serious adverse reactions were rarely observed during bortezomib therapy and included heart failure, tumor lysis syndrome, pulmonary hypertension, reversible rear encephalopathy syndrome, acute diffuse infiltrative pulmonary diseases. In addition, in rare cases, vegetative neuropathy was observed. The most frequently observed adverse events during therapy with bortezomib were nausea, diarrhea, constipation, vomiting, fatigue, pyrexia, thrombocytopenia, anemia, neutropenia, peripheral neuropathy (including sensory), headache, paresthesia, decreased appetite, dyspnea, rash, surrounding herpes and myalgia. The following are undesirable reactions that were regarded as likely or possibly related to the use of bortezomib. Undesired reactions are grouped according to system-organ classes and frequency of occurrence.
The frequency of unwanted reactions was classified as follows: very often (≥1/10), often (≥1 / 100, <1/10), infrequently (≥1 / 1000 and <1/100), rarely (≥1 / 10000 and < 1/1000) and the frequency is unknown (the frequency can not be estimated from the available data). In each frequency group, unwanted reactions are presented in order of decreasing severity.
Infections and invasions:
often - herpes simplex, surrounding herpes (incl.disseminated and ophthalmoherpes), pneumonia, fungal infections;
infectious, bacterial, viral infections, sepsis (including septic shock), bronchopneumonia, herpesvirus infection, herpetic meningoencephalitis, bacteremia (including staphylococcal), barley, influenza, inflammation of subcutaneous fat, infections, associated with the use of medical devices, skin infections, ear infections, staphylococcal infections, dental infections; rarely - meningitis (including bacterial), Epstein-Barr virus infection, genital herpes, tonsillitis, mastoiditis, chronic fatigue syndrome.
Neoplasms are benign, malignant and vague (including cysts and polyps):
rarely - malignant neoplasm, plasmacytic leukemia, kidney carcinoma, neoplasms, mushroom mycosis, benign neoplasms.
Disturbances from the hematopoiesis and lymphatic system:
very often - thrombocytopenia, neutropenia, anemia; often - leukopenia, lymphopenia;
infrequently - pancytopenia, febrile neutropenia, coagulopathy, leukocytosis, lymphadenopathy, hemolytic anemia;
rarely - disseminated intravascular coagulation (DVS-syndrome), thrombocytosis, high blood viscosity syndrome, platelet abnormalities, thrombocytopenic purpura, blood disorders, hemorrhagic diathesis, lymphocytic infiltration.
Immune system disorders:
infrequently - Quincke's edema, hypersensitivity;
rarely - anaphylactic shock, amyloidosis, reactions with the formation of immune complexes (type III).
Disorders from the endocrine system:
infrequently - the Itenko-Cushing syndrome, hyperthyroidism, a violation of the secretion of antidiuretic hormone; rarely - hypothyroidism.
Metabolic disorders and eating disorders:
very often - a decrease in appetite;
often - dehydration, hypokalemia, hyponatremia, changes in blood glucose concentration, hypocalcemia, changes in enzyme activity;
infrequently - tumor lysis syndrome, lack of weight gain, hypomagnesemia, hypophosphatemia, hyperkalemia, hypercalcemia, hypernatremia, changes in uric acid concentration, diabetes mellitus, fluid retention;
rarely - hypermagnesia, acidosis, disturbance of water-electrolyte balance, excessive accumulation of fluid,hypochloremia, hypovolemia, hyperchloremia, hyperphosphatemia, metabolic disorders, vitamin B deficiency, vitamin B12 deficiency, gout, increased appetite, alcohol intolerance.
Mental disorders:
often - disorders and mood disorders, anxiety, frustration and sleep disorders;
infrequently - changes in mental status, hallucinations, psychotic disorder, confusion, excited state;
rarely - suicidal thoughts, adaptation disorder, delirium, decreased libido.
Disturbances from the nervous system:
very often - neuropathy, peripheral sensory neuropathy, dysesthesia, neuralgia;
often - motor neuropathy, loss of consciousness (including fainting), dizziness, taste distortion, lethargy, headache;
infrequent - tremor, peripheral sensorimotor neuropathy, dyskinesia, impaired balance, memory loss (excluding dementia.), encephalopathy, posterior reversible encephalopathy syndrome, neurotoxicity, seizures, post-herpetic neuralgia, speech disorder, a syndrome of "restless legs", migraine, sciatica, impaired concentration attention, pathological reflexes, parosmia;
rarely - intracerebral haemorrhage, intracranial hemorrhage (including subarachnoid), cerebral edema, transient ischemic attack, coma, autonomic nervous system imbalance, autonomic neuropathy, cranial nerve paralysis, paralysis, paresis, pre-occlusive condition, brainstem disease syndrome, violation cerebral circulation, radicular syndrome, psychomotor hyperactivity, spinal cord compression, cognitive disorders, movement disorders, nervous system disorders, radiculitis, salivation, hypotension we шц.
Disturbances on the part of the organ of sight:
often - swelling of the eyes, visual impairment, conjunctivitis;
infrequent - eye hemorrhage, eyelid infections, eye inflammation, diplopia, dry eyes, eye irritation, eye pain, increased lacrimation, discharge from the eyes;
rarely - corneal damage, exophthalmos, retinitis, scotoma, eye damage (including age), dacryoadenitis, photophobia, photopsy, optic neuropathy, various degrees of visual impairment (before blindness).
Hearing and balance disorders:
often - vertigo;
infrequent - ringing in the ears, hearing impairment (to deafness), discomfort in the ear; rarely bleeding, vestibular neuronitis, ear damage.
Violation of the heart:
infrequently - cardiac tamponade, cardiopulmonary shock, cardiac fibrillation (including atrial fibrillation), heart failure (including left and right ventricles), arrhythmia, tachycardia, palpitations, angina, pericarditis (incl. exudative pericarditis), cardiomyopathy, ventricular dysfunction, bradycardia;
rarely - atrial flutter, myocardial infarction, atrioventricular blockade, cardiovascular disorders (including cardiogenic shock), pirouette ventricular tachysystolic type arrhythmia, unstable angina, heart valve diseases, coronary insufficiency, sinus node stop.
Disorders from the vascular system:
often - lowering blood pressure, orthostatic hypotension, increasing blood pressure;
infrequently, stroke, deep vein thrombosis, bleeding, thrombophlebitis (including superficial), circulatory collapse (including hypovolemic shock), phlebitis, hot flashes, hematoma (including perirenal), decreased peripheral circulation, vasculitis, hyperemia (including ocular);
rarely - embolism of peripheral vessels, lymphedema, pallor, erythromelalgia, vasodilation, change in color of veins, venous insufficiency.
Disturbances from the respiratory system, thorax and mediastinum:
often shortness of breath, nosebleeds, upper and lower respiratory tract infections, cough;
infrequent - pulmonary embolism, pleural effusion, pulmonary edema (including acute), pulmonary alveolar hemorrhage, bronchospasm, chronic obstructive pulmonary disease, hypoxemia, airway obstruction, hypoxia, pleurisy, hiccough, rhinorrhea, dysphonia, wheezing;
rarely respiratory failure, acute respiratory distress syndrome, apnea, pneumothorax, atelectasis, pulmonary hypertension, hemoptysis, hyperventilation, orthopnea, pneumonitis, respiratory alkalosis, tachypnea, pulmonary fibrosis, bronchial dysfunction, hypocapnia, interstitial lung disease, pulmonary infiltration, a feeling of tightness in the throat, dryness in the throat, increased secretion in the upper respiratory tract, irritation of the throat, cough syndrome of the upper respiratory tract.
Disorders from the gastrointestinal tract:
very often - nausea, vomiting, diarrhea, constipation;
often - bleeding from the gastrointestinal tract (including bleeding of the mucous membrane), dyspepsia, stomatitis, a violation of the tone of the gastrointestinal tract, pain in the throat and pharynx, pain in the abdomen (incl.gastrointestinal pain and pain in the spleen), disorders of the mouth, flatulence;
infrequently - pancreatitis (including chronic), vomiting of blood, puffiness of the lips, obstruction of the gastrointestinal tract (including intestinal obstruction), discomfort in the abdomen, ulceration of the oral mucosa, enteritis, gastritis, bleeding from the gums, gastroesophageal reflux disease, colitis (including pseudomembranous colitis), ischemic colitis, inflammation of the mucous membrane of the gastrointestinal tract, dysphagia, irritable bowel syndrome, gastrointestinal disturbances, plaque in the tongue, motor motility disorder, disorders of the salivary glands;
rarely - acute pancreatitis, peritonitis, tongue edema, ascites, oesophagitis, cheilitis, fecal incontinence, anal sphincter atony, fekaloma, ulceration, and perforation of the gastrointestinal tract, gingival hypertrophy, megacolon, discharge from the rectum, blisters in the throat, pain in the lips, periodontitis, anal fissure, change in the rhythm of defecation, procalgia, stool disorders.
Disorders from the hepatobiliary system:
often - changes in the activity of "liver" enzymes;
infrequently - hepatotoxicity (incl.hepatic disorders), hepatitis, cholestasis;
rarely - hepatic insufficiency, hepatomegaly, Badd-Chiari syndrome, cytomegalovirus hepatitis, hepatic bleeding, cholelithiasis.
Disturbances from the skin and subcutaneous tissue:
often - a rash, itching, erythema, dry skin;
infrequently - erythema multiforme, urticaria, acute febrile neutrophilic dermatosis, toxic skin eruption, toxic epidermal necrolysis, Stevens-Johnson syndrome, dermatitis, change in hair structure pitehii, ecchymosis, skin lesions, purpura, skin tumors, psoriasis, hyperhidrosis, night sweats, pressure ulcers, acne, blisters, skin pigmentation disorder;
rarely - skin reactions, lymphocytic infiltration of Jessner, palmar-plantar eritrodizesteziya, subcutaneous bleeding, livedo reticularis, skin induration, a papule, photosensitivity reactions, seborrhea, cold sweat, skin lesions, unspecified, erythrose, skin ulcer, nail infections.
Disorders from the musculoskeletal system and connective tissue:
very often - musculoskeletal pain;
often - muscle spasms, pain in the limbs, muscle weakness;
infrequently - muscle twitching, swelling of the joints, arthritis, joint stiffness, myopathy, a feeling of heaviness;
rarely - rhabdomyolysis, temporomandibular joint syndrome, fistula, joint effusion, pain in the jaw, bone disorders, infections and inflammation of the musculoskeletal and connective tissue, synovial cysts.
Disorders from the kidneys and urinary tract:
often - renal dysfunction;
infrequent - acute renal failure, chronic renal failure, urinary tract infections, urinary tract complaints, hematuria, urinary retention, urination disorder, proteinuria, azotemia, oliguria, pollakiuria;
rarely - irritation of the bladder.
Violations of the genitals and mammary gland:
infrequently - vaginal bleeding, pain in the genitals, erectile dysfunction;
rarely - dysfunction of the testicles, prostatitis, malfunction of the breast, soreness of the epididymis, epididymitis, pain in the pelvic region, ulceration of the vulva.
Congenital, family and hereditary disorders:
rarely - aplasia, malformation of the gastrointestinal tract, ichthyosis.
General disorders and disorders due to the method of application:
very often - pyrexia, increased fatigue, asthenia; often - swelling (including peripheral), chills, pain, discomfort;
infrequent general physical health, facial swelling, reactions at the injection site, mucosal disorders, chest pain, gait disturbance, cold feeling, extravasation, complications from the use of a catheter, a change in thirst, discomfort in the chest, a sense of change body temperature, pain to the injection site;
rarely - death (including sudden), multiple organ failure, bleeding at the injection site, hernia, disruption of healing processes, inflammation, phlebitis at the site of injection, tenderness, ulceration, irritability, non-cardial chest pain, pain at the site of the catheter, foreign body sensation.
Changes in laboratory indicators:
often - a decrease in body weight;
infrequently - hyperbilirubinemia, changes in protein indexes, weight gain, changes in blood counts, increased concentration of C-reactive protein;
rarely - changes in the content of gases in the blood, changes in the cardiogram (incl.augmentation QT), a change in prothrombin time, a decrease in the pH of gastric juice, an increase in platelet aggregation, an increase in troponin I concentration, a detection of viruses and a change in serology, a change in urine analysis.
Injury, poisoning and complications of procedures:
infrequently - falls, concussion;
rarely - transfusion reactions, fractures, rigidity, facial trauma, joint trauma, burns, ruptures, pain during the procedure, radiation damage.
Surgical and therapeutic procedures:
rarely - activation of macrophages.
Patients with mantle cell lymphoma
The safety indices of bortezomib in these patients were similar to those in patients with multiple myeloma. Significant differences between the two groups of patients were that thrombocytopenia, neutropenia, anemia, nausea, vomiting and pyrexia were more common in patients with multiple myeloma compared with patients with mantle cell lymphoma; and peripheral neuropathy, rash and itching - in patients with mantle cell lymphoma.